• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>Auxilium Pharmaceuticals

Auxilium Pharmaceuticals

  1. All
  2. 3rd Party
  1. Auxilium Pharmaceuticals , Inc. Announces Positive Data From Phase 2a Study Of CCH In Patients With Cellulite

    Auxilium Pharmaceuticals , Inc. Announces Positive Data From Phase 2a Study Of CCH In Patients With Cellulite

  2. Auxilium Pharmaceuticals , Inc. Announces XIAFLEX Milestone: Partner Asahi Kasei Pharma Corporation Completes Regulatory Submission For Dupuytren's Contracture In Japan

    Auxilium Pharmaceuticals , Inc. Announces XIAFLEX Milestone: Partner Asahi Kasei Pharma Corporation Completes Regulatory Submission For Dupuytren's Contracture In Japan

  3. Auxilium Pharmaceuticals , Inc. Appoints Andrew Saik Chief Financial Officer

    Auxilium Pharmaceuticals , Inc. Appoints Andrew Saik Chief Financial Officer

  4. Auxilium Pharmaceuticals , Inc. To Announce Second Quarter 2014 Results On August 7, 2014

    Auxilium Pharmaceuticals , Inc. To Announce Second Quarter 2014 Results On August 7, 2014

  5. BioSpecifics Technologies Corp. Announces Positive Data from Phase 2a Study of CCH for Treatment of Cellulite

    BioSpecifics Technologies Corp. Announces Positive Data from Phase 2a Study of CCH for Treatment of Cellulite

  6. BioSpecifics Technologies Corp. Reports Second Quarter 2014 Financial Results

    BioSpecifics Technologies Corp. Reports Second Quarter 2014 Financial Results

  7. 'Inversion' payoff for shareholders is muted at tax time

    'Inversion' payoff for shareholders is muted at tax time

  8. UPDATE: 'Inversion' payoff for shareholders is muted at tax time

    UPDATE: 'Inversion' payoff for shareholders is muted at tax time

  9. Pharmaceutical Firms Get the Urge to Merge

    Morningstar analysts see pharmaceuticals as 2010's hot zone for mergers and acquisitions.

Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.